<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oncology Product Guide &#187; Guided Therapeutics</title>
	<atom:link href="http://www.oncologyproductguide.com/blog/tag/guided-therapeutics/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.oncologyproductguide.com/blog</link>
	<description>A comprehensive guide to oncology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 12:00:01 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Guided Therapeutics Non-Invasive Cervical Cancer Detection Device Trial Confirms Current Tests Miss Disease</title>
		<link>http://www.oncologyproductguide.com/blog/2009/11/26/guided-therapeutics-non-invasive-cervical-cancer-detection-device-trial-confirms-current-tests-miss-disease/</link>
		<comments>http://www.oncologyproductguide.com/blog/2009/11/26/guided-therapeutics-non-invasive-cervical-cancer-detection-device-trial-confirms-current-tests-miss-disease/#comments</comments>
		<pubDate>Thu, 26 Nov 2009 15:17:28 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Cervical Cancer]]></category>
		<category><![CDATA[cervical precancers]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Guided Therapeutics]]></category>
		<category><![CDATA[LightTouch Non-invasive Cervical Cancer Detection Device]]></category>
		<category><![CDATA[National Cancer Institute]]></category>

		<guid isPermaLink="false">http://www.oncologyproductguide.com/blog/?p=178</guid>
		<description><![CDATA[Results of the FDA pivotal clinical trial for the LightTouch Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI). In the new LightTouch study, 32% of [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/11/Guided-Therapeutics.png"><img class="alignleft size-full wp-image-179" style="margin: 5px" src="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/11/Guided-Therapeutics.png" border="0" alt="Guided Therapeutics" width="200" height="64" /></a>Results of the FDA pivotal clinical trial for the LightTouch Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI). In the new LightTouch study, 32% of cervical precancers and cancers were missed by the current method of human papillomavirus (HPV) testing and colposcopy.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.oncologyproductguide.com/blog/2009/11/26/guided-therapeutics-non-invasive-cervical-cancer-detection-device-trial-confirms-current-tests-miss-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
